Biotage Financial Statements From 2010 to 2025
| BITGFDelisted Stock | USD 15.01 0.00 0.00% |
Check Biotage AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotage AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biotage financial statements analysis is a perfect complement when working with Biotage AB Valuation or Volatility modules.
Biotage |
Biotage AB OTC Stock Current Valuation Analysis
Biotage AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biotage AB Current Valuation | 1.17 B |
Most of Biotage AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotage AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Biotage AB has a Current Valuation of 1.17 B. This is 91.87% lower than that of the sector and 87.23% lower than that of the Current Valuation industry. The current valuation for all United States stocks is 92.98% higher than that of the company.
Biotage AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotage AB's current stock value. Our valuation model uses many indicators to compare Biotage AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotage AB competition to find correlations between indicators driving Biotage AB's intrinsic value. More Info.Biotage AB is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biotage AB is roughly 1.64 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotage AB's earnings, one of the primary drivers of an investment's value.About Biotage AB Financial Statements
Biotage AB stakeholders use historical fundamental indicators, such as Biotage AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biotage AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biotage AB's assets and liabilities are reflected in the revenues and expenses on Biotage AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biotage AB. Please read more on our technical analysis and fundamental analysis pages.
Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Biotage OTC Stock
If you are still planning to invest in Biotage AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotage AB's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |